Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | TACR1 | P25103 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29125864 | 0.87 | — | — | |
| SCHEMBL29125832 | 0.85 | KMT2A (0.45) | TSHRKMT2AMMP13HSD17B10ALDH1A1 | |
| SCHEMBL29125676 | 0.73 | KMT2A (0.34) | KMT2AMMP13 | |
| SCHEMBL29125813 | 0.71 | TSHR (0.46) | TSHRKMT2AMMP13HSD17B10ALDH1A1 | |
| SCHEMBL29125693 | 0.71 | TSHR (0.46) | TSHRKMT2AMMP13HSD17B10ALDH1A1 | |
| SCHEMBL29125853 | 0.70 | DAO (0.45) | DAO | |
| SCHEMBL29125718 | 0.68 | TSHR (0.46) | TSHRKMT2AMMP13HSD17B10ALDH1A1 | |
| SCHEMBL29126036 | 0.68 | TSHR (0.46) | TSHRKMT2AMMP13HSD17B10ALDH1A1 | |
| SCHEMBL29125947 | 0.68 | TSHR (0.40) | TSHRKMT2AMMP13HSD17B10ALDH1A1 | |
| SCHEMBL4049551 | 0.62 | TSHR (0.63) | TSHRKMT2AMMP13HSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117247361-A | Phenol-oxazolone/thioketone compound and synthetic method and application thereof | 吉首大学 | 2023-12-19 | — | — | CN | disclosed |